Literature DB >> 7102427

Brain dysfunction following vasospasm evaluated by somatosensory evoked potentials.

A Suzuki, N Yasui, Z Ito.   

Abstract

Somatosensory evoked potentials (SEP) were recorded in 9 patients with vasospasm caused by subarachnoid haemorrhage. There was a correlation between SEP changes and clinical outcome evaluated one month after onset. And, evaluation of SEP changes under induced hypertension or infusion of dehydrates was available to study the nature of ischaemic brain dysfunction caused by vasospasm. Furthermore, this study suggests that the available period of induced hypertension may be short in cases with severe clinical outcomes.

Entities:  

Mesh:

Year:  1982        PMID: 7102427     DOI: 10.1007/BF01728855

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  5 in total

1.  Postoperative hypertension in the management of patients with intracranial arterial aneurysms.

Authors:  E J Kosnik; W E Hunt
Journal:  J Neurosurg       Date:  1976-08       Impact factor: 5.115

2.  Reversal of ischemic neurological signs by increasing the cardiac output.

Authors:  G D Vander; M Pomerantz
Journal:  Surg Neurol       Date:  1973-09

3.  Angiographic changes to induced hypertension in cerebral vasospasm. Case report.

Authors:  L C De Araujo; R A Zappulla; W C Yang; S A Hollin
Journal:  J Neurosurg       Date:  1978-08       Impact factor: 5.115

4.  Disordered cerebro-vascular physiology in aneurysmal subarachnoid haemorrhage.

Authors:  L Symon
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

5.  Central conduction time as an index of ischaemia in subarachnoid haemorrhage.

Authors:  L Symon; J Hargadine; M Zawirski; N Branston
Journal:  J Neurol Sci       Date:  1979-12       Impact factor: 3.181

  5 in total
  1 in total

1.  Evaluation of cerebral vasospasm in patients with subarachnoid hemorrhage using single photon emission computed tomography.

Authors:  S Naderi; M A Ozgüven; H Bayhan; H Gökalp; A Erdoğan; N Egemen
Journal:  Neurosurg Rev       Date:  1994       Impact factor: 3.042

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.